Endo receives India clearance to acquire domestic subsidiaries
US-based diversified healthcare company Endo Inc received clearance from the Indian antitrust watchdog to acquire 100 percent of the shares of its domestic subsidiaries, Endo India Holdings, Par Formulations, Par Active...To view the full article, register now.
Already a subscriber? Click here to view full article